Holen Sie sich die Stockscreener-App
24.18
1.10%
-0.27
Handel nachbörslich:
24.01
-0.17
-0.70%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter International (NYSE:BAX) Shares Acquired Rep. Lisa C. McClain - MarketBeat
Forsta AP Fonden Sells 188,100 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Baxter's Novum IQ Infusion Pump Safety Crisis: Implications for Medical Device Investors - AInvest
Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 33% Undervaluation? - au.finance.yahoo.com
Baxter International Inc. (NYSE:BAX) Shares Sold by Russell Investments Group Ltd. - MarketBeat
Trend Dashboard Flags Baxter International Inc. As Potential Swing TradeJuly 2025 Weekly Recap & Real-Time Price Movement Reports - beatles.ru
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Baxter downgraded to Hold at Stifel on weak Q2 report - MSN
Baxter International (BAX) Is Up 7.2% After Profitable Q2 and Raised Sales GuidanceWhat's Changed - simplywall.st
Here’s Why You Should Consider Selling Your Baxter (BAX) Shares - Insider Monkey
Ascites Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | PharmaIN, AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company - The Globe and Mail
Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda - Yahoo Finance
Baxter to split into two companies - The Covington News
Morgan Stanley Keeps Sell Rating on Baxter International with $19 Target - AInvest
Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing - Fierce Healthcare
Baxter International (BAX) Is Up 7.9% After Reversing Losses and Reaffirming 2025 Sales Growth Outlook - simplywall.st
UBS Group Cuts Baxter International (NYSE:BAX) Price Target to $24.00 - MarketBeat
Baxter International's GF Score Indicates Potential for Underperformance - AInvest
FDA's IV Shortage Resolution Lifts Baxter's Volume to 394th Rank as Stock Rises 0.64% - AInvest
Barclays Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - MarketBeat
Baxter International's (BAX) Hold Rating Reiterated at Stifel Nicolaus - MarketBeat
Arkadios Wealth Advisors Acquires Shares of 17,245 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. shares rise 1.98% intraday after ATS Corporation reported Q1 revenue growth and provided Q2 revenue guidance. - AInvest
Baxter International Inc. (NYSE:BAX) Shares Bought by Raiffeisen Bank International AG - MarketBeat
Are Wall Street Analysts Bullish on Baxter International Stock? - MSN
LSV Asset Management Sells 391,800 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International 2025 Q2 Earnings Strong Turnaround as Net Income Surges 129% - AInvest
Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast - MSN
Baxter International Inc. (BAX): A Bull Case Theory - Insider Monkey
Wall Street Zen Downgrades Baxter International (NYSE:BAX) to Hold - MarketBeat
Baxter International Surges 1.78% on $330M Volume Ranking 363rd as Tactical Strategy Outperforms Benchmark by 137.53 Pts - AInvest
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International (NYSE:BAX) Updates FY 2025 Earnings Guidance - MarketBeat
Baxter International (NYSE:BAX) Downgraded by The Goldman Sachs Group to "Neutral" - MarketBeat
Stifel Downgrades Baxter International (BAX) - MSN
Baxter slashes its profit forecast after disappointing quarter - Medical Buyer
Barclays Lowers Price Target on Baxter International to $36 From $41, Maintains Overweight Rating - MarketScreener
Baxter downgraded at Stifel on weak Q2 report (BAX:NYSE) - Seeking Alpha
Stifel downgrades Baxter as it sees longer path to recovery under new CEO - Investing.com Canada
Baxter’s shares fall 23% following tepid Q2 2025 financials - Yahoo Finance
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Baxter slumps as Medical Products & Therapies drive Q2 revenue miss - MSN
Stifel Downgrades Baxter International to Hold From Buy, Adjusts Price Target to $25 From $36 - MarketScreener
Baxter International (NYSE:BAX) Hits New 52-Week Low After Earnings Miss - MarketBeat
Baxter: Stifel downgrades to ’Hold’, cuts PT on disappointing Q2 results - Investing.com
What is Baxter International Inc. company’s growth strategyRemarkable growth - Jammu Links News
How does Baxter International Inc. compare to its industry peersCapitalize on emerging trends for profits - Jammu Links News
Baxter International (NYSE:BAX) Updates Q3 2025 Earnings Guidance - MarketBeat
How strong is Baxter International Inc. company’s balance sheetMaximize profits with strategic stock selection - Jammu Links News
2.43%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):